FDA Denies Small Pharma Company’s Request for GDUFA Facility Fee Waiver

Generic Line
The Generic Drug User Fee Amendments of 2012 do not allow for a waiver, reduction or postponement of finished dosage form (FDF) facility fees for small and/or foreign businesses, the FDA says in a letter denying a citizen petition submitted by Square Pharmaceuticals.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00